[#DIV28SUPER] APA Divisions 28 and 55 Psychopharmacology Seminar Series

All,

By way of this e-mail, I want to announce a joint seminar series that will be co-hosted by APA Divisions 28 and 55 focused on psychopharmacology.  The plan is to have a virtual seminar held quarterly each year.  

The first seminar will be held tomorrow, Friday March 31st, at 11am EST.  I will be the guest speaker and will be discussing the human behavioral pharmacology of cannabis.  For anyone interested in attending, here is a link to the seminar:

https://us02web.zoom.us/j/86560361556?pwd=a2FYWnFrNTQ2bFEyb3JFRlU3YU5QUT09 

VERY sorry for the late announcement on this, totally my fault.  I expect that we will get a little better organized with this first seminar taking place and will announce the next speaker with much greater advanced notice and a more fancy advertisement/flyer ;-)  

We are also hoping to arrange for CE credits for this seminar series at some point, but that has not yet been realized for this first session.

If you are interested in being a speaker for one of these events in the future, please e-mail me.

Feel free to share with others who may be interested in attending.

Regards,

-Ryan

________________

Ryan Vandrey, Ph.D.

Past-President

APA Division 28

http://www.apadivisions.org/division-28/index.aspx

[#DIV28SUPER] Postdoctoral training in Alcohol and Addiction Research at the University of Missouri

Postdoctoral Fellowships in Alcohol and Addiction Research
Department of Psychological Sciences
University of Missouri

 

The Department of Psychological Sciences and the Department of Psychiatry at the University of Missouri (MU) are recruiting POSTDOCTORAL RESEARCH FELLOWS IN ALCOHOL AND ADDICTION RESEARCH. Our training grant has been supported by the National Institute of Alcohol Abuse and Alcoholism (NIAAA) since 2002 (T32AA013625; see more here). Positions are available through both the NIH training grant (only US citizens and permanent residents can be considered) and the University of Missouri (no residency limitations).

 

Research mentors include:

• Mary Beth Miller – Health Intervention & Treatment Research Lab (see HIT lab website)
• Sean Lane – Regulation of Emotion, Addiction, and Conflict Trajectories (see REACT lab website)
• Denis McCarthy – Alcohol Cognitions Lab (see website)
• Brett Froeliger – Health Neuroscience Center (see website)
• Bruce Bartholow – Social Cognitive and Addiction Neuroscience Lab (see SCAN lab website)
• Ian Gizer – Gene Brain Behavior Relations Lab
• Clint Davis-Stober – Behavioral Decision-Making Lab (see website)
• Tim Trull – Personality and Emotion Lab (see website)
• Doug Steinley – Multivariate Statistics Lab, with primary interest in cluster analysis and social network analysis

 

 

Postdoctoral research fellows will undertake advanced training in addictions and pursue their own research interests under the supervision of one or more faculty mentors. The goals of the training program are (1) to support the individual development of diverse early career scientists who want to conduct addictions research; (2) to provide hands-on training in grant writing, data analysis, and research design; and (3) to foster collaborative relationships with addiction scientists and community stakeholders locally and across the nation. Positions begin summer 2023 and are available for up to 3 years of training. Fellowship stipends are decided by NIH and based on the status of the fellow; for example, fellows with no prior postdoctoral training start at $54,840 (more detail here). See more about NRSA service payback here.

 

Please submit the following application materials as a single (one) combined PDF to Carol Waudby at waudbyc@missouri.edu:

• Statement of research/training interests – summarize your current interest and expertise, long-term career goals, how postdoctoral training would facilitate those goals, the mentors with whom you would like to work, and how your work incorporates or applies to people of historically underrepresented backgrounds (including but not limited to race, ethnicity, sexual orientation, gender identity, national origin, and the differently abled). The statement should be no longer than 3-4 pages.
• List of 3-5 professional references
• Curriculum vitae

 

Please contact Denis McCarthy at mccarthydm@missouri.edu with questions or concerns. You are also welcome to contact your proposed future research mentor directly.

 

The University of Missouri does not discriminate on the basis of race, color, religion, national origin, ancestry, sex, age, disability, status as disabled veteran, or veteran of Vietnam era.

 

 

 

 

 

Kenneth J. Sher, Ph.D.

Chancellor’s Professor of Psychological Sciences and

Curators’ Distinguished Professor Emeritus

University of Missouri

210 McAlester Hall

Columbia, MO 65211

Tel: 573-268-0006

Email: sherk@missouri.edu

 

[#DIV28SUPER] Division 49 Institute: Developing Diverse and Diversity-Minded Future Leaders

Hi everyone,

I am sending the following message on behalf of Division 49:

We still have space for new members in the Division 49 Institute! The goal of the Institute is to raise attention to the cultural, social, and political contexts that are a part of group psychology and group psychotherapy. By striving to counteract historical oppressions and marginalization, we hope to envision a subdiscipline, and our larger field of psychology, as one that honors and uplifts all people. This can only be accomplished by understanding issues of oppression and marginalization from the perspective of those who are a part of these groups.

Over two years, participants in the Institute will:

Engage in mentorship with Division 49 leaders
Network and develop working relationships with Division 49
Observe and participate in portions of the Division 49 Board meetings including mid-winter meeting and the APA convention
Develop and execute a leadership project that contributes to increasing awareness of issues related to diversity, equity, and inclusion in group psychology and group psychotherapy and present the results at the APA Convention
Reflect and raise one's own awareness of issues related to diversity and social justice and develop skills to continuously engage in cultural humility


Please see our flyer for more information: https://acrobat.adobe.com/link/track?uri=urn:aaid:scds:US:fa938aec-9547-45f7-b07d-4d70e22e981e


To enroll in the Institute, please complete the application found at: https://forms.office.com/r/KKNF6ZFj0Q

_____________________ div28SUPER@lists.apa.org _____________________
Div28m members #div28 subscribers corner: http://lists.apa.org

[#DIV28SUPER] Call for comments - APA's initial decisions in updating the 2017 clinical practice guideline for treatment of PTSD in adults

Dear Division 28 Members,

 

The American Psychological Association (APA) invites you to review and comment on the guideline update panel’s (GUP) initial decisions in updating its 2017 Clinical practice guideline for the treatment of PTSD in adults. The online public comment form is available until 11:59 pm (ET) Friday, April 21, 2023.

 

The GUP has made initial decisions on the framework of the guideline update and systematic reviews of empirical evidence that will be used to develop guideline recommendations (per best practices for guideline development; for further details see Institute of Medicine’s [2011; now National Academy of Medicine] Clinical practice guidelines we can trust) within that scope.

 

The framework is defined in terms of population, intervention, comparator, outcome, timing, and setting (PICOTS) elements.

 

You can access the PDF supporting documents and the online comment form at the following link: https://www.apa.org/about/offices/directorates/guidelines/adults-ptsd-treatment-public-comment

 

Public input on the adequacy of initial guideline decisions is important for maximizing utility of the final guideline for all stakeholders. The GUP carefully considers all comments received and intends to may make modifications to the guideline update process and final recommendations based on these considerations.

 

We would highly value your input given your expertise in this domain. Please forward the announcement to colleagues who may be interested in participating in this opportunity.,

 

If you have any difficulty in accessing or using the online form, please send an email to cpg@apa.org. For more information about APA’s work in developing clinical practice guidelines please click here. Any additional questions may be directed to Raquel Halfond, PhD, Senior Director, Evidence-Based Practice & Health Equity, at rhalfond@apa.org.

 

Thank you!  

 

 

Jacob S. Marzalik, MA (he/him/his)

Project Manager, Clinical Practice Guidelines

Practice Transformation and Quality, Practice Directorate

American Psychological Association

  

750 First Street NE, Washington DC 20002-4242

202-336-5872

 

All APA staff are teleworking until further notice and are experiencing a high volume of inquiries related to COVID-19. For immediate information and resources, visit APA's COVID-19 page for psychologists, health-care workers, and the public.

 

[#DIV28SUPER] Opportunity to Comment on AHRQ's Draft Report - Nonpharmacological and Pharmacological Treatments for PTSD

Dear Division 28 Colleagues,

 

The Agency for Healthcare Research and Quality (AHRQ) posted a draft report on Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the Evidence Base for the PTSD Trials Standardized Data Repository. The draft report is available for review and public comment until March 28, 2023. We encourage you to consider submitting comments directly to AHRQ!

 

https://effectivehealthcare.ahrq.gov/products/ptsd-pharm-nonpharm-treatment-update-draft-report

 

Our office plans to review and submit comments as well and you are welcome to share your comments with us if you wish. If you would like to share your comments with our office, please email them to jmarzalik@apa.org by the end of the day Monday, March 27.

 

For any questions, please contact Dr. Raquel Halfond, Senior Director, Evidence-Based Practice and Health Equity, at rhalfond@apa.org.

 

Thank you,

 

 

Jacob S. Marzalik, MA (he/him/his)

Project Manager, Clinical Practice Guidelines

Practice Transformation and Quality, Practice Directorate

American Psychological Association

  

750 First Street NE, Washington DC 20002-4242

202-336-5872

 

All APA staff are teleworking until further notice and are experiencing a high volume of inquiries related to COVID-19. For immediate information and resources, visit APA's COVID-19 page for psychologists, health-care workers, and the public.

 

[#DIV28SUPER] APA Div 28 award winners for 2023

Please join APA Division 28 in congratulating the winners of the 2023 APA Div 28 awards.

 

Outstanding Dissertation Award nominations are evaluated on the overall scientific merit of the dissertation project and quality of the dissertation document, completed within the past 2 years. The 2023 winner is C. Austin Zamarripa, Ph.D.

 

Young Psychopharmacologist Award nominations are evaluated on the overall body of accomplishments during the early career stage (within 10 years of doctoral degree), as indicated by activity and engagement in the scientific research enterprise, as well as the investigator’s potential to continue to make impactful and substantive contributions. The 2023 winner is Tory Spindle, Ph.D.

 

MED Associates Brady-Schuster Award nominations are evaluated on a sustained record (at least 15 years past doctoral degree) of conducting and publishing high quality scientific research, with particular emphasis on a body of work that has had a lasting impact. The 2023 winner is Adam M. Leventhal, Ph.D.

 

Richard Yi, Ph.D.

Professor, Department of Psychology

Director, Cofrin-Logan Center for Addiction Research and Training

University of Kansas

Lawrence, KS 66045

[#DIV28SUPER] Update from APA Council of Representatives

Dear Division 28 Colleagues-

Please find attached a brief summary from the APA Council of Representatives meeting this past week.

Let me know if you have any questions.

Thanks,

Bill Stoops, Division 28 Council Representative.

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383

Professor
Departments of Behavioral Science, Psychiatry and Psychology
Center on Drug and Alcohol Research
University of Kentucky

Director
Regulatory Knowledge and Support Core-Center for Clinical and Translational Science

Clinical Research Support Office

Associate Director for Clinical Research

Substance Use Priority Research Area

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

[#DIV28SUPER] Postdoctoral Position open with JHU Maryland Opioid Research team

Dear colleagues,

Come join the Maryland Opioid Research Team! ( www.marylandopioidresearch.com )

The Johns Hopkins University School of Medicine invites applications for postdoctoral research fellowships at the Behavioral Pharmacology Research Unit (BPRU) within the Department of Psychiatry and Behavioral Sciences. Fellows receive research training in the clinical pharmacology of substance use including human laboratory studies and clinical treatment trials. Fellows benefit from experienced faculty and a NIDA-funded T32 training grant with a productive 40-year history and over 130 graduates. Fellows work closely with faculty mentors to gain practical research experience and develop as productive independent scholars.

Areas of interest: This postdoctoral fellow will work with Drs Kelly Dunn and Andrew Huhn in the area of opioid use disorder. Fellows will have the opportunity to gain experience in clinical trials, human laboratory drug administration studies, and treatment outcomes studies. Research in the Dunn and Huhn labs cover a broad range of topics, including the treatment of opioid use disorder, opioid withdrawal, sleep, emotional processes, chronic and acute pain, and abuse liability of opioids and other medications. These studies employ diverse methodology including ecological momentary assessments, sleep electroencephalography (EEG), ambulatory monitoring of daily activity and sleep, quantitative sensory testing of pain, genetics, and biological assays of stress and inflammation. Prospective candidates should have a strong interest in medication studies and/or utilizing advanced statistical analyses (e.g., machine learning). The selected candidate would also have the opportunity to collaborate with multiple BPRU faculty across different projects.

Eligibility: Eligible applicants must be a U.S. citizen or permanent resident and have completed doctoral degree requirements (e.g., PhD, MD, DO, PsyD) prior to starting at BPRU. Many backgrounds are appropriate, including experimental or clinical psychology, pharmacology, psychiatry or other medicine, neuroscience, nursing, public health, and social work. Prior experience with human or nonhuman research is appropriate. The BPRU is particularly interested in candidates who can contribute to the diversity and excellence of our research program. Applications from persons with disabilities, protected veterans, and persons underrepresented in science are strongly encouraged.

Start date: Flexible.

To Apply please send your CV and letter of interest to Kelly E. Dunn, Ph.D, MBA (kdunn9@jhmi.edu) and Andrew S. Huhn, Ph.D., MBA (ahuhn1@jhmi.edu)

Johns Hopkins University is an equal opportunity/affirmative action employer committed to recruiting, supporting, and fostering a diverse community.

-----
Kelly E. Dunn, Ph.D., MBA

Professor | Psychiatry and Behavioral Sciences
School of Medicine
Johns Hopkins University
5510 Nathan Shock Dr, Baltimore, MD 21224
O: 410-550-2254; Email: kdunn9@jhmi.edu

Schedule a zoom meeting with me directly: https://calendly.com/kelly_dunn

[#DIV28SUPER] APA Div 28: Open Archivist position

Hello all,

We're looking for someone to serve as the new Archivist on the APA Division 28 executive committee.

The division Archivist is a 3-year appointed position. Primary duties include: (1) Maintaining an electronic record of all relevant Division 28 materials; and (2) soliciting oral or written histories of individuals who contributed to Division 28.

Joining the executive committee is an excellent way to serve the division, and I believe the burden of labor for this position is relatively low. If you're interested in joining the committee in this capacity, please email Tom Gould (cc'd here) or me for more information.

Thank you,

Matt

Matthew Kirkpatrick, PhD

Associate Professor of Research, Department of Population and Public Health Sciences

USC Drug Use & Behavior Laboratory (PI)

https://dublab.usc.edu/

Keck School of Medicine

University of Southern California

Phone: 323-442-8221

Re: [#DIV28SUPER] APA approved Div 28 name change: PLEASE VOTE

Greetings colleagues,

I would also like to draw attention to and thank our former President Wendy Lynch, who originated the plan to remove stigmatizing language from our organizational name during her Presidency.

Warm regards,

Kelly

-----
Kelly E. Dunn, Ph.D., MBA

Professor | Psychiatry and Behavioral Sciences
School of Medicine
Johns Hopkins University
5510 Nathan Shock Dr, Baltimore, MD 21224
O: 410-550-2254; Email: kdunn9@jhmi.edu

Schedule a zoom meeting with me directly: https://calendly.com/kelly_dunn

---

From: div28super reaches div28 and div28m and its nested lists (e.g. div28s) <DIV28SUPER@LISTS.APA.ORG> on behalf of Matthew Kirkpatrick <mgkirkpa@USC.EDU>
Sent: Wednesday, March 1, 2023 10:17 AM
To: DIV28SUPER@LISTS.APA.ORG <DIV28SUPER@LISTS.APA.ORG>
Subject: [#DIV28SUPER] APA approved Div 28 name change: PLEASE VOTE

 

I'm sending this on behalf of APA Division 28 President Tom Gould:

-----------------------------------------

Dear Members of Division 28,

Division 28's name change to The Society for Psychopharmacology and Substance Use has been approved by APA. To officially complete this process, we need to ratify with a member vote a change to the By-Laws to reflect the new name. Please use the link below to either indicate your support [Yes] or your opposition [No] to the name change.  

https://usc.qualtrics.com/jfe/form/SV_eKdXvsdt1HZPiOW

I want to thank our past Presidents Ryan Vandrey and Kelly Dunn, and the member of the Div 28 Executive who worked to bring this about.

Sincerely,

Tom

Thomas J. Gould, Ph.D.

Jean Phillips Shibley Professor of Biobehavioral Health

Department Head

Department of Biobehavioral Health

219 Biobehavioral Health Bldg

The Pennsylvania State University

University Park, PA 16802

814-863-7256

President of the Society for Psychopharmacology and Substance Use

Div 28 of the American Psychological Association

http://www.apadivisions.org/division-28/index.aspx

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] APA approved Div 28 name change: PLEASE VOTE

I'm sending this on behalf of APA Division 28 President Tom Gould:

-----------------------------------------

Dear Members of Division 28,

Division 28's name change to The Society for Psychopharmacology and Substance Use has been approved by APA. To officially complete this process, we need to ratify with a member vote a change to the By-Laws to reflect the new name. Please use the link below to either indicate your support [Yes] or your opposition [No] to the name change.  

https://usc.qualtrics.com/jfe/form/SV_eKdXvsdt1HZPiOW

I want to thank our past Presidents Ryan Vandrey and Kelly Dunn, and the member of the Div 28 Executive who worked to bring this about.

Sincerely,

Tom

Thomas J. Gould, Ph.D.

Jean Phillips Shibley Professor of Biobehavioral Health

Department Head

Department of Biobehavioral Health

219 Biobehavioral Health Bldg

The Pennsylvania State University

University Park, PA 16802

814-863-7256

President of the Society for Psychopharmacology and Substance Use

Div 28 of the American Psychological Association

http://www.apadivisions.org/division-28/index.aspx